Skip to main content
. 2023 Jan 13;24(2):1559. doi: 10.3390/ijms24021559

Figure 2.

Figure 2

The mechanism of treatment for patients with uremic pruritus STAT3; Signal transducer and activator of transcription 3, GRP; Gastrin-releasing peptide, GRPR; Gastrin-releasing peptide receptor, LCN2; Lipocalin-2, NPRA; Natriuretic peptide receptor-A, NPPB; Natiurtetic polypeptide b, GABA; Gamma-aminobutyric acid, Bhlhb5; Basic helix-loop-helix B 5, TRPV1; Transient receptor potential vanilloid type 1, TRPM8; Transient receptor potential melastatin 8.